vx-745 has been researched along with tubocurarine in 1 studies
| Studies (vx-745) | Trials (vx-745) | Recent Studies (post-2010) (vx-745) | Studies (tubocurarine) | Trials (tubocurarine) | Recent Studies (post-2010) (tubocurarine) |
|---|---|---|---|---|---|
| 58 | 1 | 35 | 4,661 | 149 | 52 |
| Protein | Taxonomy | vx-745 (IC50) | tubocurarine (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 9.6 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 9.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egbert, M; Keserű, GM; Vajda, S; Whitty, A | 1 |
1 other study(ies) available for vx-745 and tubocurarine
| Article | Year |
|---|---|
Why Some Targets Benefit from beyond Rule of Five Drugs.
Topics: Binding Sites; Drug Discovery; Ligands; Molecular Weight; Protein Binding | 2019 |